2026 Latest Pass4training ALS-Con-201 PDF Dumps and ALS-Con-201 Exam Engine Free Share: https://drive.google.com/open?id=1G8qVOYbmIAbUR9O5_0fhkx6LaaMVFLQa
If you really want to pass the ALS-Con-201 exam faster, choosing a professional product is very important. Our ALS-Con-201 study materials can be very confident that we are the most professional in the industry's products. We are constantly improving and just want to give you the best ALS-Con-201 learning braindumps. And we have engaged for years to become a trustable study flatform for helping you pass the ALS-Con-201 exam.
| Certification Vendor: | Salesforce |
|---|---|
| Exam Name: | Salesforce Certified Agentforce Life Sciences Consultant |
| Exam Number: | Als-Con-201 |
| Real Exam Qty: | 60 |
| Exam Duration: | 105 minutes |
| Exam Format: | Multiple Choice, Multiple Select |
| Passing Score: | 63% |
| Exam Price: | $200 USD |
| Certificate Validity Period: | 2 years |
| Related Certifications: | Salesforce Certified Sales Cloud Consultant Salesforce Certified Administrator |
| Available Languages: | English |
| Sample Questions: | Salesforce ALS-Con-201 Sample Questions |
| Exam Way: | Online proctored exam |
| Pre Condition: | Recommended: Salesforce Certified Administrator and Salesforce Certified Sales Cloud Consultant certifications; experience with Salesforce Health Cloud |
| Official Syllabus URL: | https://trailhead.salesforce.com/credentials/agentforce lifes sciences consultant |
>> ALS-Con-201 Pdf Demo Download <<
Our ALS-Con-201 real exam dumps are specially prepared for you. Try our ALS-Con-201 study tool and absorb new knowledge. After a period of learning, you will find that you are making progress. The knowledge you have studied on our ALS-Con-201 exam question will enrich your life and make you wise. Do not reject challenging yourself. Your life will finally benefit from your positive changes. Let us struggle together and become better. Then you will do not need to admire others’ life. Our ALS-Con-201 Real Exam dumps will fully change your life.
| Topic | Details |
|---|---|
| Topic 1 |
|
| Topic 2 |
|
| Topic 3 |
|
| Topic 4 |
|
NEW QUESTION # 115
Choose 1 option.
Cumulus Pharma wants to allocate samples from a specific production batch to a field sales rep's inventory so the company can track the remaining quantity by batch and automatically update inventory during disbursements.
Which action fulfills this requirement?
Answer: C
Explanation:
Option C is correct because Product Batch Item is the Salesforce Life Sciences Cloud record that connects a production batch to a specific product inventory location or user inventory context. Salesforce Help describes creating Product Batch Items for sample inventory and states that a product batch item establishes the relationship between the Product, Life Science Marketable Product, Production Batch, Product Batch Item, Location, and User. This directly matches the scenario: Cumulus Pharma needs to allocate samples from a specific production batch to a field sales rep's inventory and track remaining quantity at the batch level.
The ProductBatchItem object also includes the RemainingQuantity field, which supports the requirement to track remaining quantity by batch. Salesforce's Life Sciences Cloud Developer Guide documents ProductBatchItem and identifies RemainingQuantity as a field on the object.
Option A is incorrect because simply assigning a Production Batch to the Life Sciences Marketable Product does not allocate batch-specific stock to a rep's inventory. Visit submissions can update inventory, but the batch allocation must already be represented correctly. Option B is also incorrect because updating Quantity on Hand on Product Item only changes general product inventory at a location. It does not establish the production-batch relationship needed for batch-level tracking. Therefore, the consultant should create a Product Batch Item, associate it to the rep's Product Item, mark it Active, and enter the Remaining Quantity.
=========
NEW QUESTION # 116
Choose 1 option.
A Cumulus Pharma field sales rep uses the Medical Insights feature in Agentforce Life Sciences for Customer Engagement to record insights from engagements with Healthcare Providers (HCPs). The company also uses an external system to generate intelligence from medical insights collected through various sources.
Which configuration sends the medical insights captured by the rep to the external system without delay?
Answer: C
Explanation:
The correct answer is B because the requirement is to send Medical Insights to an external system without delay, which points to an event-driven integration pattern. Salesforce's Life Sciences Cloud Developer Guide defines MedicalInsight as important information observed or heard through outlets such as meetings, calls, or research and used to inform strategy or follow-up. For near-real-time downstream processing, the appropriate Life Sciences configuration is to publish the standard Medical Insight platform event by activating the handler designed for that purpose.
Activating PublishMedicalInsightEventHandler allows newly captured Medical Insight data to be published as a MedicalInsightEvent platform event. Platform events are the correct Salesforce pattern when an external system needs to subscribe and react quickly as records are created or changed. This avoids waiting for scheduled jobs, exports, or manual data transfers, and it supports timely intelligence generation from field-captured insights.
Option A is incorrect because creating a custom platform event is unnecessary when the Life Sciences feature provides a standard MedicalInsightEvent mechanism. Custom events add avoidable implementation and maintenance complexity. Option C is also incorrect because MedicalInsightIntegrationHandler is not the specific handler described for publishing the MedicalInsightEvent platform event. The key words in the question are "without any delays," which make an event-based publishing configuration the best fit. Therefore, the consultant should activate PublishMedicalInsightEventHandler.
=========
NEW QUESTION # 117
Choose 1 option.
Cumulus Pharma requires that once a field sales rep finalizes and submits a visit report, it must become immutable and no further edits should be allowed.
Which configuration ensures this behavior?
Answer: C
Explanation:
The correct answer is C because the requirement is to lock a submitted visit report so it can no longer be edited. Salesforce Life Sciences Visit Management supports compliant planning, execution, and reporting for provider visits, and Salesforce Help directs administrators to use the Visit Management Admin Console to configure what fields users can see and how users can interact with and manage visit records.
A submitted visit report often represents a compliance-sensitive record, especially in life sciences, where visit details, sampling activity, consent capture, and inquiry handling may need to remain auditable after submission. Enabling VisitLockHandler enforces the locking behavior, while leaving Unlock submitted visit unchecked prevents the record from being reopened or edited after final submission. This configuration best matches the requirement that the submitted visit report become immutable.
Option A is incorrect because VisitAutoSaveHandler relates to saving visit data, and checking "Allow edits after submission" would contradict the stated requirement. The business specifically wants no further edits after submission. Option B is also incorrect because disabling a permissions handler and setting the status to Closed does not directly enforce immutable submitted-visit behavior. Status alone is not the same as a record lock. Therefore, the consultant should enable VisitLockHandler and ensure submitted visits remain locked by unchecking Unlock submitted visit in the Admin Console.
=========
NEW QUESTION # 118
Choose 1 option.
Cumulus Pharma requires strict governance over its Healthcare Provider (HCP) master data to ensure regulatory compliance. Any changes to critical compliance fields, such as Medical License Number, must be routed to a Data Steward for verification and approval.
What should the Agentforce Life Sciences Consultant recommend?
Answer: B
Explanation:
Option B is correct because Salesforce Life Sciences Cloud provides a standard Data Change Requests framework for governed master-data updates. The requirement is not simply to block a change or create a manual task; it is to route critical HCP data changes to a Data Steward for review before the change is applied. Salesforce's Life Sciences Cloud Account Management documentation describes Data Change Requests as a capability used to validate data changes by objects and fields and configure data changes by profile and record type. That aligns directly with controlled governance over fields such as Medical License Number.
The specific configuration object in the question, LifeSciDataChgPersonaDef, represents the persona-based data-change configuration. Salesforce's Developer Guide identifies LifeSciDataChgPersonaDef as part of Data Change Requests and includes the ChangeUpdateType picklist field. Setting ChangeUpdateType to DoNotApplyChangesImmediately means changes are not applied directly by the sales rep persona and can instead be managed through the data-change governance process.
Option A is not the best answer because a custom record-triggered flow would duplicate standard Life Sciences Cloud data-change governance and could create maintenance or compliance risk. Option C is also not ideal because a validation rule only blocks the update; it does not create the governed change-request process needed for Data Steward review. Salesforce's Data Change Requests data model includes Life Science Data Change Definition, managed fields, record types, persona definitions, and Life Science Data Change Request, confirming this is the intended standard architecture.
=========
NEW QUESTION # 119
Choose 1 option.
Cumulus Pharma uses Agentforce Account Summary to provide the latest and most relevant account information before each Healthcare Provider (HCP) interaction. The company is onboarding a new persona for its Key Account Managers (KAMs). Provider account summaries generated for this new persona need information from two additional custom objects that store insights and market intelligence.
Which configuration ensures the new information is used only while generating the provider summary for this new persona?
Answer: B
Explanation:
Option A is correct because Account Summarization uses cross-object graphs to determine which related objects and relationships are included in generated summaries. Salesforce Life Sciences Account Summarization setup resources reference creating a cross-object graph for Account Summarization and assigning cross-object graphs to an org or profile. This supports persona-specific summary behavior because a graph can be configured with the additional custom objects and then assigned specifically to the KAM profile.
The requirement says the new information must be used only for the new KAM persona. That means the consultant should avoid changing the default or shared provider summary mapping used by other personas. By creating a separate cross-object graph from the template, adding the two custom insight and market-intelligence objects, and assigning that graph only to the KAM profile, the consultant isolates the new summary structure to the intended users.
Option B is not the best answer because globally updating Provider Summary Objects mapping could affect more than the KAM persona if the mapping is shared. Option C is also not the best answer because the key Account Summarization configuration pattern documented by Salesforce is graph creation and graph assignment to an org or profile. Therefore, the correct configuration is to create a new cross-object graph and assign it to the KAM profile.
=========
NEW QUESTION # 120
......
Valid Braindumps ALS-Con-201 Book: https://www.pass4training.com/ALS-Con-201-pass-exam-training.html
P.S. Free & New ALS-Con-201 dumps are available on Google Drive shared by Pass4training: https://drive.google.com/open?id=1G8qVOYbmIAbUR9O5_0fhkx6LaaMVFLQa